Phase II Trial of Natalizumab + Prednisone for Initial Therapy of Acute GI GVHD

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2015
This research study is a Phase II clinical trial, which tests the safety and effectiveness of an investigational drug Natalizumab in treating Acute Graft-Versus-Host Disease (GVHD) in the Gastrointestinal (GI) Tract.
Epistemonikos ID: 8fd200ef355d4a9f6093714c53978cba7db2eb34
First added on: May 11, 2024